Oracle Investment Management as of Sept. 30, 2024
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 22 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Genedx Holdings Corp Com Cl A (WGS) | 26.6 | $44M | 1.0M | 42.44 | |
| Biohaven (BHVN) | 21.1 | $35M | 705k | 49.97 | |
| Biohaven Call Call Option | 9.1 | $15M | 303k | 49.97 | |
| Phathom Pharmaceuticals (PHAT) | 8.1 | $14M | 750k | 18.08 | |
| Spdr Ser Tr Call Call Option | 5.9 | $9.9M | 100k | 98.80 | |
| Ardelyx (ARDX) | 5.7 | $9.4M | 1.4M | 6.89 | |
| Novavax Call Call Option | 4.0 | $6.8M | 535k | 12.63 | |
| Quidel Corp (QDEL) | 3.2 | $5.4M | 118k | 45.60 | |
| BioCryst Pharmaceuticals (BCRX) | 2.4 | $4.1M | 536k | 7.60 | |
| Myriad Genetics (MYGN) | 2.2 | $3.7M | 135k | 27.39 | |
| Phathom Pharmaceuticals Call Call Option | 2.1 | $3.5M | 193k | 18.08 | |
| Ardelyx Call Call Option | 1.8 | $3.0M | 430k | 6.89 | |
| Forian Ord (FORA) | 1.8 | $2.9M | 1.4M | 2.16 | |
| Eyepoint Pharmaceuticals Call Call Option | 1.7 | $2.8M | 350k | 7.99 | |
| Cava Group Ord (CAVA) | 1.4 | $2.3M | 19k | 123.85 | |
| Pacific Biosciences of California (PACB) | 0.7 | $1.2M | 728k | 1.70 | |
| Springworks Therapeutics (SWTX) | 0.7 | $1.1M | 34k | 32.04 | |
| Palantir Technologies Cl A (PLTR) | 0.6 | $1.0M | 28k | 37.20 | |
| Palantir Technologies Call Call Option | 0.4 | $744k | 20k | 37.20 | |
| Biogen Idec (BIIB) | 0.3 | $468k | 2.4k | 193.84 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.2 | $260k | 33k | 7.99 | |
| Biodesix (BDSX) | 0.0 | $52k | 29k | 1.78 |
